MMS
Maximus, Inc.87.77
+1.27+1.47%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
4.95BP/E (TTM)
15.93Basic EPS (TTM)
5.51Dividend Yield
0.01%Recent Filings
10-K
8-K
8-K
Maximus expands stock buyback to $400M
Maximus's board approved an expansion of its stock repurchase program to $400 million on September 8, 2025, building on $32.7 million remaining from the prior authorization. The company will buy shares opportunistically in open markets or via 10b5-1 plans, guided by market conditions and capital needs. This move underscores disciplined capital returns amid strong momentum in government services. Yet purchases remain flexible, with no fixed timeline or obligation.
10-Q
Q3 FY2025 results
Maximus posted solid Q3 FY2025 results, with revenue climbing 2.5% y/y to $1.35B on organic gains in federal clinical programs, while gross margins expanded to 26.7% from 25.3% thanks to volume boosts and fewer penalties. Operating income rose 16.9% y/y to $166M, driving diluted EPS up 27.4% to $1.86 amid share buybacks; YTD figures show 3.1% revenue growth to $4.11B and EPS of $4.20, reconciling cleanly with 58.1M diluted shares. Federal services led with 11.4% q/q revenue surge to $761M, but U.S. Services dipped on normalized Medicaid volumes, and international revenue fell 7.5% y/y post-Australia/Korea divestiture in December 2024 for nominal cash plus up to $5M contingent. Cash dipped to $60M amid billing delays, offset by $310M revolver draw on $1.67B total debt (5.5% effective rate, covenants met); free cash flow not disclosed in the 10-Q. Delays in federal and state payments strained liquidity, though resolutions are underway.
8-K
Maximus raises FY25 guidance
Maximus reported Q3 fiscal 2025 revenue up 2.5% to $1.35 billion, with adjusted diluted EPS rising to $2.16 from $1.74 year-over-year, fueled by 11.4% growth in U.S. Federal Services to $761.2 million amid elevated clinical volumes. While U.S. Services dipped 6.9% due to normalized Medicaid activity, the company raised full-year guidance to $5.375-$5.475 billion in revenue and $7.35-$7.55 adjusted EPS. Cash flows strained temporarily from payment delays. Strong federal momentum offsets segment variances.
IPO
Website
Employees
Sector
Industry
AMTM
Amentum Holdings, Inc.
29.13-0.22
ASGN
ASGN Incorporated
47.75-0.20
BKSY
BlackSky Technology Inc.
17.97+0.45
CBZ
CBIZ, Inc.
53.49+0.11
DLHC
DLH Holdings Corp.
5.65+0.08
LDOS
Leidos Holdings, Inc.
182.16-3.79
MAN
ManpowerGroup
29.31-0.23
MNTS
Momentus Inc.
0.52+0.06
MSA
MSA Safety Incorporated
159.27-1.07
QUAD
Quad Graphics, Inc
6.54-0.01